Our board of directors
P.Eng, B.Sc., I.E.
Director of Business Development, Stantec
Ben Lee brings over 25 years of experience in all aspects of Project Management. He has successfully delivered over $1B in major projects in the biotechnology, pharmaceutical, hospital and manufacturing sectors from concept to completion.
Mr. Lee has comprehensive knowledge and practice of current GMP, GLP, FDA and CFR 21 Part 11. He possesses direct and extensive experience in project planning such as benefit-cost analysis, life cycle costing, feasibility studies, change control, operational/technical requirements, analysis & optimization, functional/space programming, land use and environmental approvals. Mr. Lee has been invited to speak at several associations, including the ISPE conference as a keynote speaker.
President, QIE Consulting
David has over 20 years of experience in the pharmaceutical industry in various roles from Research, Vaccine Production, CSV Compliance and Project Management. Areas of specialization pertain specifically to computer system implementations for all types of CSV systems from simple Lab systems to Global Custom CRM / ERP systems. He is a mentor and collaborative leader, who leads by example, experience and a thorough knowledge of current IT / manufacturing practices. In addition, Mr. McSweeney is an instructor at NSU and AAPS for CSV. David is recognized for his high personal standards for performance and ensuring that all aspects of compliance and data integrity are captured during implementations.
Honour B.A., Labour Studies with minor in Sociology
Donna is a committed human resource leader with more than 20 years of progressive experience in both the pharmaceutical and medical device industry, Donna has held senior level positions including the Vice President of Human Resources for AgMedica Bioscience Inc. Her knowledge spans across all areas of human resources, championing the building or restructuring of the function in different countries. Donna believes in the importance of education and holds a business degree, a Bachelor of Arts in Labour Studies & Sociology, a Human Resources Management Certificate, and a CHRP, along with a few development courses related to human resources. In addition, she has been an instructor at Sheridan College. Along her career, Donna has been charged with restructuring complicated human resources functions in multiple locations simultaneously. As a member of the executive team, she has been responsible for developing initiatives in talent acquisition, training & development, succession planning, performance management, organizational restructuring, and competency models, amongst others, to ensure the HR function is in line with the business structure. Donna is also a Board Member with BioTalent Canada.
CPA, CA, FP&A
Senior Accountant, Taro Pharmaceuticals Inc.
Faraz is a Chartered Professional Accountant with extensive experience across functional areas of financial accounting and reporting under IFRS and ASPE, management reporting, analysis and forecasting, system designing, audit, taxation and general accounting. He is currently working as Senior Accountant at Taro Pharmaceuticals Inc., a research-based, international, specialty pharmaceutical company listed on NYSE that develops, manufactures and markets prescription and over-the-counter pharmaceutical products. Faraz started his career with PricewaterhouseCoopers and has worked at various organizations across the service and manufacturing sectors.
VP, Global Generic Pipeline & Business Development, Pharmascience
Kent has been in the Pharmaceutical Industry since 1990 working in Health Canada and later within the industry responsible to lead product development, regulatory affairs, business development, product registration and patent litigation. He was previously the Vice-President, Scientific Affairs-Canada and Latin at Actavis. Kent has been a member of the PSG Board of Directors since 2011, and is also a member of the Annual Conference Committee. Kent holds a B.Sc. in Microbiology from the University of Manitoba.
B.Sc. Chemistry, B.S.P. Pharmacy, M.Sc.Phm. Pharmacy, Ph.D. Health Economics
Director, Health Technology Assessment, Emerging Markets, Eli Lilly & Company
Manny Papadimitropoulos graduated in Pharmacy from the University of Saskatchewan and has worked in retail pharmacy, the pharmaceutical industry, and academia over the last 25 years. His pharmacy experience has been primarily in health economics, and clinical research. He has a master's in Pharmacy and a Ph.D. in Health Economic Evaluation from the University of Toronto in Canada. Manny is currently the Director of Health Technology Assessment – Emerging Markets at Eli Lilly and Company. He is also an adjunct assistant professor at the University of Toronto, Faculty of Pharmacy, in the Administrative/Social Pharmacy area. Manny’s areas of research are in HTA and decision analysis, and is a supervisor of four graduate students.
Senior Scientific Advisor. Chemistry, Health Canada
Graduating with an Hons. B.Sc. in Chemistry from the University of Toronto in 1982, Arvin has been involved in the pharmaceutical industry since 1983 working as a laboratory chemist in the private sector with the majority of his career being in the area of regulatory oversight of the pharmaceutical industry in Canada. Arvin joined Health Canada in 1989 after pursuing a Masters degree in Synthetic Organic Chemistry at Memorial University of Newfoundland. Arvin started his Government career as a Senior Evaluator in the Bureau of Pharmaceutical Surveillance reviewing generic drug submissions. Using this experience, Arvin held the position of Manager, Generic Drugs Quality Division (1996 – 2009) with the Bureau of Pharmaceutical Sciences and currently is Senior Scientific Advisor – Chemistry in the Director's Office within the same Bureau of Therapeutic Products Directorate of HPFB. Furthermore, he has been called upon to represent BPS in the legal arena and at the World Health Organization for a number of years as a Consultant for the Pre-Qualification of Drugs Programme which is responsible for providing approved generic drug products for Africa and Asia.
Chief Operating Officer at New Maple Holding
Chetan has an MBA from Rotman School of Management at the University of Toronto, and is a mechanical engineer. He has led global teams spanning 16 facilities in the Americas, Europe and Asia in diverse industries including, biotechnology, composites, and chemical manufacturing. He has successfully delivered multimillion dollar capital projects globally and has a proven record of turning underperforming operations to best in class.
He is the Chief Operating Officer at New Maple Holdings, a diversified cannabis holding company where he is responsible for the overall operational management of the company. His previous employers include Sanofi Pasteur, Honeywell, Owens Corning & Siemens, where he held various management and leadership positions.
Charles M. Chee
B.Sc., Honours Co-op Biology, Biology
Qing Bile Therapeutics Inc., Co-Founder
Charles Chee is a Regulatory Compliance veteran with over 35 years in the Pharmaceutical and Biotech industry. Charles is Co-Founder of Qing Bile Therapeutics Inc., a research and development pharmaceutical company engaged in finding cures to clinical disorders associated with Bile Acid imbalance. Most recently, Charles served as Vice President of Quality Assurance at LifeLabs, Corporate Vice President of Quality at Biovail Pharmaceuticals Corporation, and Vice President of Quality at Torpharm (Apotex). Charles holds a Bachelor's degree in Honours Biology from the University of Waterloo, a Certificate in Business Administration from Ryerson University and a Graduate Diploma in Christian Studies from Tyndale University College and Seminary. In the community, Charles continues to serve on several non-profit organizations.
Ph.D. MBA P.Eng RAC
Hologic Inc., Director of Design Quality
Yuan currently serves as the Director of Design Quality at Hologic Inc., and serves as a member of the Board of Directors of several private medical device companies. Yuan worked at the U.S. Food and Drug Administration for 8+ years and as the acting Branch Chief and team lead, he led multidisciplinary review teams for 150+ medical device premarket submissions (including PMA, IDE, 510(k) and 513(g)) and 100+ compliance assignments (inspections, warning letter resolutions, recalls, ARO and trade complaints). Yuan received the prestigious FDA Outstanding Service Award for his contributions and expertise in Total Product Life Cycle (TPLC) management and the lead author on the FDA Guidance for the Submission of 510(k)s for Solid State X-ray Imaging Devices. Yuan received his PhD majoring in Electrical Engineering from the University of Waterloo, MBA from Ivey Business School - Western University and is a licensed Professional Engineer (P.Eng) in the province of Ontario.
J.D., Ph.D. Chemistry, M.Sc. Chemistry, B.A. Chemistry
Partner, Blaney McMurtry LLP
Junyi practices intellectual property law with an emphasis on patent litigation and general IP matters in the areas of pharmaceuticals and other health sciences. She has appeared frequently before the Federal Court and the Federal Court of Appeal. Junyi is a Registered Patent Agent and Registered Trademark Agent in Canada, and has extensive experience in patent and trademark prosecution matters and licensing. Junyi is fluent in Mandarin and has frequently represented Chinese clients in patent and trademark litigation and in procuring their IP rights in Canada.
MBA Business, B.Sc. and M.Sc. Microbiology
AvP, Global Head R&D Product CMC Portfolio and Clinical Supply Chain, Sanofi Pasteur
Joan Bevilacqua has more than 30 years of experience in the pharmaceutical industry, specifically in Vaccine development and licensure. Currently she is the Global Head of R&D Product CMC Portfolio and Clinical Supply Chain, Sanofi Pasteur. Her career has spanned across several vaccine areas, and has included roles in analytical strategy and development of new analytical methods in Quality Control and in R&D as Head of Analytical Research & Development North America, in Clinical Development, and as Global R&D Project Leader. As Global Project Leader, she has successfully led seven new vaccine license submissions in Canada, US , and Europe. Over the years, she has had direct experience in cGMP, cGLP, cGRP, and in strategic lifecycle management of the vaccines globally. As a seasoned leader at Sanofi Pasteur, Joan has had the opportunity to be involved in the design and delivery of a number of strategic corporate business simplification and efficiency programs as well in a several employee development initiatives, in addition to being an employee mentor/coach and a member of the Joint Labour Management Committee.
B.A. Commerce and Economics
President, North America Operations, Bora Pharmaceuticals
In his current role as President, North American Operations at Contract Development and Manufacturing Organization (CDMO), Bora Pharmaceuticals, Sam Ricchezza is responsible for advancing the North American growth of the company and any North American acquisition plans.
Sam has more than 25 years’ CDMO experience, and prior to joining Bora, he was President of WellSpring Pharma Services and led the company through a sale of the business. Before that, he previously held progressively responsible Business Development and Marketing roles at companies such as Patheon, DPT Labs, AAIPharma (Alcami) and Diteba Research Laboratories.
Sam has also held Board positions with the Pharma & Biopharma Outsourcing Association, where he served as Secretary of the Board of Trustees and Board Member for the Niagara Escarpment Biosphere Fund.
Ex-Officio, Advisory Board Representative
B.Sc. Pharm. D.T.M.
President, Zipharm International Inc.
Max is a board member, former Chairman of PSG Annual Conference Committee, and past Acting Executive Director of the PSG. As a pharmacist and entrepreneur, he is president and founder of Genpharm Inc., a major Toronto generic pharmaceutical company; part of an international group of pharma companies located in England, Ireland, Australia, New Zealand and Europe.
Max has been involved in substantial humanitarian activities, providing medicines and related humanitarian donations to third-world countries in Africa, Europe and Asia, valued at approximately $60 million. These included sizable contributions to Red Cross in North and South Vietnam for four consecutive years. Furthermore, Max visited/inspected Red Cross clinics, hospitals and humanitarian organizations in Vietnam. Max is also president and founder of Zipharm International Inc. Toronto, which provides specialized consulting services to the pharma industry relating to regulatory, government, and business affairs.
Amanda is a highly motivated and outgoing professional with over 10 years of experience in both the Pharmaceutical and Event Coordinating Industries. In addition to being a Principal Planner for a successful business, she also has an extensive background in Microbiology and Quality Control. Her career highlights include starting her own event coordinating business as well as working her way up from a Microbiology Analyst to the Department Head of Microbiology for a large contract laboratory in Toronto. She is always looking for ways to develop her skills and has been involved in many committees along her career including being an active member of the Pharmaceutical Sciences Group as well as the Hiring Committee at Seneca College School of Biological Sciences and Applied Chemistry.
Shirley is a Registered Dietitian with a background in providing clinical nutrition care, education and nutrition-related program planning. She completed her Masters of Health Science at Ryerson University and has experience in nutrition-related research and knowledge translation methods. She is committed to professional learning and growth and is excited to be part of the professional development initiatives at the PSG.
Lynn completed her Bachelor of Mathematics/Business Administration at University of Waterloo and has a wealth of experience in both customer service and administrative support. She is highly organized and able to work on several projects simultaneously and meet the deadlines with deliverable results. She is always striving to work hard for our members and is proud to be part of PSG team.